Learn More
Phospho-ELK1 (Thr417) Polyclonal Antibody, Invitrogen™
Description
A suggested positive control for IHC is human breast carcinoma; suggested positive control for ICC/IF is Hela cells.
Specifications
Specifications
| Antigen | Phospho-ELK1 (Thr417) |
| Applications | Immunocytochemistry, Immunohistochemistry (Paraffin) |
| Classification | Polyclonal |
| Concentration | 1 mg/mL |
| Conjugate | Unconjugated |
| Formulation | PBS with 50% glycerol and 0.02% sodium azide; pH 7.4 |
| Gene | ELK1 |
| Gene Accession No. | A4GTP4, P19419, P41969 |
| Gene Alias | ELK 1; ELK1; Elk-1; ELK1, ETS transcription factor; ELK1, member of ETS oncogene family; ETS domain-containing protein Elk-1; ETS transcription factor ELK1; ETS-like gene 1; Oncogene Elk1; tyrosine kinase (ELK1) oncogene |
| Gene Symbols | ELK1 |
| Show More |
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.